title: Naturopathic management of females with cervical atypia: a delphi process to explore current practice.
abstract: BACKGROUND
  Human papillomavirus is the most significant factor contributing to cervical cancer. Naturopathic doctors (NDs) implement an integrative approach to treat cervical atypia. This study explored practice consensus and variance among NDs.
  
  
  METHODS
  A purposefully selected panel of six NDs participated in a modified Delphi study to validate practice. Three electronic web-based surveys were completed over nine months.
  
  
  RESULTS
  Local and systemic treatments were included in all ND protocols. Six protocols included cervical cancer screening guidelines, green tea suppositories, and oral folic acid. Five protocols included oral green tea, diindoylemethane (DIM), and cartenoids. Four protocols incorporated Vitamin C. Two NDs considered escharotics when managing cervical atypia. All NDs included health behavior management in their protocols.
  
  
  CONCLUSIONS
  Naturopathic management of cervical atypia varies across practitioners. However, in general, elements of management include (1) cervical cancer screening guidelines, (2) local and systemic treatments, (3) health behavior/lifestyle recommendations, and (4) immune system support.
authors: National Institutes of Health, National Institute of Nursing Research, Bethesda, MD.
authors: Cynthia Ann
authors: CA
authors: Leaver
authors: Claiborne
authors: C
authors: Miller-Davis
authors: Gwenyth R
authors: GR
authors: Wallen
keywords: cervical atypia; naturopathic medicine
references: Int J Cancer. 2011 Jul 15;129(2):449-59
references: 20853322
references: J Altern Complement Med. 2011 Oct;17(10):967-72
references: 21978217
references: J Clin Pathol. 2002 Apr;55(4):244-65
references: 11919208
references: Ethn Dis. 2007 Spring;17(2 Suppl 2):S2-14-7
references: 17684808
references: Twin Res Hum Genet. 2012 Feb;15(1):79-86
references: 22784457
references: J Womens Health (Larchmt). 2009 Aug;18(8):1133-43
references: 19630554
references: DNA Cell Biol. 2003 Mar;22(3):217-24
references: 12804120
references: Integr Cancer Ther. 2009 Jun;8(2):164-7
references: 19679625
references: Gynecol Oncol. 2000 Aug;78(2):123-9
references: 10926790
references: Best Pract Res Clin Obstet Gynaecol. 2005 Aug;19(4):469-83
references: 16150388
references: Dis Markers. 2007;23(4):315-30
references: 17627065
references: Dis Markers. 2007;23(4):213-27
references: 17627057
references: Int J Cancer. 2013 Mar 1;132(5):1133-45
references: 22752881
references: Prim Care. 2010 Mar;37(1):119-36
references: 20189002
references: Lancet Infect Dis. 2010 Dec;10(12):862-74
references: 21075056
references: Arch Dermatol. 2002 Dec;138(12):1593-6
references: 12472348
references: J Natl Compr Canc Netw. 2010 Dec;8(12):1388-416
references: 21147903
references: J Natl Cancer Inst. 1993 Jun 16;85(12):958-64
references: 8388478
references: J Altern Complement Med. 2006 Apr;12(3):323-8
references: 16646733